ERDERA launches Clinical Trial Call 2026 to advance early‑phase clinical trials for rare diseases The ERDERA Clinical Trial Call 2026 is open to fund multinational, sponsor-led, GCP-compliant Phase I, Phase I/II and Phase II interventional Clinical trials in rare...